ANDA Requirements

ANDA requirements are the eligibility conditions and evidence standards a generic drug must satisfy before it can be considered for approval. These requirements give an Abbreviated New Drug Application the proof base needed to show that the proposed generic medicine can depend on an already approved reference drug instead of being treated as a completely new drug. Because the application is abbreviated, these requirements are narrower than what a new drug application demands — the focus is on proving sameness rather than proving original safety and effectiveness from the beginning.

Generic Drug Eligibility

A proposed generic drug must be eligible for the ANDA pathway before approval can be considered. This means the medicine should be based on an already approved reference drug and should not require the same original approval route used for a completely new drug.

Same Active Ingredient

One key ANDA requirement is that the generic drug must contain the same active ingredient as the approved reference medicine. The active ingredient is the drug substance responsible for the intended effect, so matching this part helps support the generic approval pathway.

Dosage Form and Strength

The proposed generic medicine usually needs the same dosage form and strength as the approved reference drug. For example, if the reference product is a tablet of a certain strength, the generic product must match that required form and amount for comparison.

Route of Administration

The route of administration must also match the approved reference medicine. A generic drug taken by mouth, injected, applied to the skin, or used in another route must follow the same route required for the reference product in the ANDA pathway.

Reference Drug Dependence

ANDA requirements depend on comparison with an already approved reference drug. The reference drug gives the application a regulatory basis because the proposed generic medicine is judged against a product that has already passed the original approval process.

Evidence of Sameness

The application must provide evidence that the proposed generic drug is sufficiently the same as the approved medicine in required areas. This evidence helps show that the product belongs in the generic approval pathway rather than the new drug approval pathway.

Approval Standard

ANDA requirements create the approval standard for a generic medicine. They do not describe how the company files the application or how the regulator reviews it step by step. They define what must be true for the generic drug to qualify under the ANDA route.

These requirements explain why an Abbreviated New Drug Application can focus on proving generic sameness instead of building a new medicine case from the beginning. The basic expansion and meaning of the term are introduced in the main ANDA full form article.